Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More

COVID-19 impact: Indian aviation sector may lose $4 billion in FY21, says CAPA India

CAPA India, which had earlier pegged the losses at $3.6 billion, also said that the Indian aviation sector could be reduced to two or three players.

July 03, 2020 / 07:43 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More


The Indian aviation sector is likely to lose up to $4 billion in the financial year 2021, advisory firm CAPA India has said, raising the loss estimate from the earlier $3.6 billion.

In a report released on July 3, CAPA India also talked of a higher capitalisation need for Indian airlines, up from $2.5 billion to $3.5 billion.

Critically, the firm said the Indian aviation sector may be reduced to just two to three players, from more than half a dozen now, including Air India, IndiGo, SpiceJet and GoAir.


"Consolidation is looking more likely and will result in a very significant change in the structure of the industry. India may be headed for a two-three airline market if timely recapitalisation does not happen," it said.

Pointing out that the demand in the domestic market was soft, the firm said that the second quarter, like the first, could be a washout. Domestic flights resumed on May 25.


Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"Recent traffic has mostly comprised of essential repositioning traffic, with passengers that were stuck in the wrong place when the lockdown was announced returning to their home base. Discretionary travel has been limited, as reflected in the fact that more than 90 percent of bookings have been for one-way travel, compared with 40 percent prior to COVID," the report said.

Though the government has allowed airlines to operate up to 45 percent of their summer schedule but it has made little difference as passenger load hovers around the half-way mark. Fares, which have been capped within a range, have tended to be closer to the lower end of the band, CAPA India said.





Moneycontrol News
first published: Jul 3, 2020 03:53 pm

stay updated

Get Daily News on your Browser
Sections